What is the dose for a heparin bolus in Acute Coronary Syndrome (ACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The dose for a heparin bolus in Acute Coronary Syndrome (ACS) is 60 units/kg (maximum 5,000 units) for unstable angina and non-ST-segment elevation myocardial infarction, and 60 units/kg (maximum 4,000 units) when given in conjunction with fibrinolytic agents for treatment of ST-segment elevation myocardial infarction.

Key Points

  • The American College of Cardiology recommends a heparin bolus of 60 to 70 units/kg (maximum 5,000 units) followed by an infusion of 12 to 15 units/kg/h (maximum 1,000 units/h) for unstable angina and non-ST-segment elevation myocardial infarction 1.
  • When heparin is given in conjunction with fibrinolytic agents for treatment of ST-segment elevation myocardial infarction, the recommended bolus is about 60 units/kg (maximum 4,000 units) and the infusion is 12 units/kg/h (maximum of 1,000 units/kg/h) 1.
  • Weight-based dosing of 60 to 70 U/kg of heparin is used in primary PCI, rather than fixed bolus or ACT-guided dosing 1.
  • The effective biological half-life of heparin increases from ≈30 minutes after an IV bolus of 25 U/kg to 60 minutes with an IV bolus of 100 U/kg, and unfractionated heparin has heterogeneous anticoagulation effects and multiple limitations 1.
  • Monitoring of aPTT and full weight adjustment of heparin may decrease the risk of non-cerebral bleeding complications 1.

From the FDA Drug Label

Table 1: Recommended Adult Full-Dose Heparin Regimens for Therapeutic Anticoagulant Effect *Based on 68 kg patient METHOD OF ADMINISTRATION FREQUENCY RECOMMENDED DOSE Intermittent Intravenous Injection Initial Dose 10,000 units, either undiluted or in 50 to 100 mL of 0. 9% Sodium Chloride Injection, USP

The dose for a heparin bolus in Acute Coronary Syndrome (ACS) is 10,000 units by intermittent intravenous injection, as an initial dose. 2

From the Research

Heparin Bolus Dose in Acute Coronary Syndrome (ACS)

  • The recommended initial heparin bolus dose for patients with ACS is 60 U/kg (maximum, 4000 U) when administered with alteplase for ST-elevation myocardial infarction 3.
  • For patients with non-ST elevation myocardial infarction and unstable angina, an initial bolus of 60 to 70 U/kg (maximum, 5000 U) is recommended 3.
  • A study published in 2008 found that the most frequent bolus dose used in practice was 5,000 U (42.7%) 4.
  • Another study published in 1995 compared a standard-care nomogram with a weight-adjusted nomogram and found that the weight-adjusted nomogram, which used an 80 U/kg IV bolus, achieved adequate anticoagulation more rapidly 5.
  • The goal of heparin therapy is to achieve an activated partial thromboplastin time (aPTT) of 50 to 70 seconds 3.

Factors Affecting Heparin Dosing

  • Excess weight-adjusted heparin bolus or infusion dose is associated with an increased risk of major bleeding 4.
  • Factors such as age and female sex are strongly associated with excess weight-adjusted dosing 4.
  • The relationship between weight-adjusted heparin dose and major bleeding does not vary independently by sex or age 4.

Recent Guidelines and Recommendations

  • Recent guidelines specify that a bolus of unfractionated heparin is recommended during percutaneous coronary intervention in certain circumstances, such as if the patient is receiving a non-vitamin K antagonist oral anticoagulant or if the international normalized ratio is <2.5 in a patient being treated with a vitamin K antagonist 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.